— Know what they know.
Not Investment Advice

DRRX NASDAQ

DURECT Corporation
1W: +0.0% 1M: +0.0% 3M: +218.3% 1Y: +30.8% 3Y: -71.1% 5Y: -88.8%
$1.91
Last traded 2025-09-11 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $59.3M mcap · 26M float · 4.51% daily turnover · Short 45% of daily vol

Balance Sheet Trends

Total Assets
$18M -59.4% ▼
5Y CAGR: -26.6%
Total Liabilities
$9M -69.7% ▼
5Y CAGR: -31.9%
Shareholders Equity
$9M -38.2% ▼
5Y CAGR: -16.8%
Cash & Investments
$12M -60.2% ▼
5Y CAGR: -28.8%
Total Debt
$2M -89.4% ▼
5Y CAGR: -39.1%
Net Debt
-$9M -15.0% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$21M$50M$43M$28M$11M
Short-Term Investments$19M$20M$0$1M$792K
Cash & ST Investments$41M$70M$43M$30M$12M
Net Receivables$940K$6M$3M$1M$453K
Inventory$2M$2M$2M$2M$106K
Other Current Assets$15M$4M$2M$2M$813K
Total Current Assets$63M$82M$51M$35M$13M
Property, Plant & Equip.$5M$4M$2M$4M$2M
Goodwill & Intangibles$6M$6M$6M$6M$3M
Long-Term Investments$1M$20M$150K$150K$150K
Other Non-Current Assets$411K$411K$256K$278K$123K
Total Non-Current Assets$13M$10M$9M$11M$5M
Total Assets$76M$92M$60M$45M$18M
— Liabilities —
Accounts Payable$2M$1M$3M$2M$309K
Short-Term Debt$884K$0$21M$17M$0
Deferred Revenue$0$98K$0$0$0
Other Current Liabilities$0$4M$0$6M$2M
Total Current Liabilities$11M$10M$34M$27M$8M
Long-Term Debt$20M$21M$0$0$0
Other Non-Current Liab.$873K$884K$851K$1M$384K
Total Non-Current Liabilities$25M$24M$1M$3M$2M
Total Liabilities$36M$34M$35M$30M$9M
— Equity —
Common Stock$20K$23K$23K$23K$23K
Retained Earnings-$490M-$526M-$561M-$589M-$597M
Accumulated OCI-$5K-$10K-$13K-$14K-$1K
Total Stockholders Equity$40M$58M$25M$15M$9M
Total Liabilities & Equity$76M$92M$60M$45M$18M
— Key Metrics —
Total Debt$26M$24M$23M$21M$2M
Net Debt$5M-$26M-$20M-$8M-$9M
Total Investments$20M$40M$150K$1M$942K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms